Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It...

Area of Science:

• Neurology
• Metabolic Disorders
• Biochemistry

Background:

• Perturbed energy metabolism, particularly glucose metabolism, is a key pathogenic mechanism in Amyotrophic Lateral Sclerosis (ALS).
• Significant differences in disease severity and prognosis exist between spinal onset ALS and bulbar onset ALS.
• Understanding metabolic variations between ALS subtypes may offer insights into disease progression and treatment.

Purpose of the Study:

• To investigate metabolic differences between spinal onset ALS and bulbar onset ALS.
• To explore the relationship between metabolic profiles and muscle function in ALS patients.
• To identify potential markers for disease severity and prognosis.

Main Methods:

• A descriptive, analytical, quantitative, and transversal study was conducted.
• Measurements included fasting glucose, alkaline phosphatase (AP), muscle mass, fat percentage, muscle strength (MRC scale), and functional capacity (Barthel Index).
• 31 ALS patients (20 spinal, 11 bulbar) and 29 healthy controls were analyzed.

Main Results:

• No significant differences in blood AP and glucose levels were found between spinal and bulbar onset ALS.
• A positive correlation between AP and glucose levels was observed in spinal onset ALS patients.
• Spinal onset ALS patients exhibited lower muscle mass, higher fat percentage, reduced muscle strength, and lower functional capacity.

Conclusions:

• Metabolic differences, potentially indicating peripheral glucose utilization variations and insulin resistance, may exist between bulbar and spinal onset ALS.
• These metabolic differences could contribute to the poorer muscle mass and function observed in spinal onset ALS.
• Further research is warranted to elucidate the precise mechanisms and clinical implications of these findings.